Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Falk

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Dairy Science|February 10, 2004
DairyBeef: maximizing quality and profits--a consistent food safety messageD A Moore, J H Kirk, D J Klingborg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45Stephanie M Stanford, Rekha G Panchal, Logan M Walker, et al.
Journal of Medicinal Chemistry|February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cellsStephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Neurogastroenterology and Motility|November 13, 2020
Prokinetic actions of luminally acting 5-HT<sub>4</sub> receptor agonistsJohn R Konen, Melody M Haag, Daria Guseva, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 19, 2016
German registry of paediatric deep brain stimulation in patients with childhood-onset dystonia (GEPESTIM)A Koy, M Weinsheimer, K A M Pauls, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutationsHelen Y Zou, Qiuhua Li, Lars D Engstrom, et al.
The New England Journal of Medicine|June 4, 2013
Acquired resistance to crizotinib from a mutation in CD74-ROS1Mark M Awad, Ryohei Katayama, Michele McTigue, et al.
Journal of Medicinal Chemistry|December 28, 2020
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)Hengmiao Cheng, Suvi T M Orr, Simon Bailey, et al.
The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Dairy Science|February 10, 2004
DairyBeef: maximizing quality and profits--a consistent food safety messageD A Moore, J H Kirk, D J Klingborg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45Stephanie M Stanford, Rekha G Panchal, Logan M Walker, et al.
Journal of Medicinal Chemistry|February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cellsStephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Neurogastroenterology and Motility|November 13, 2020
Prokinetic actions of luminally acting 5-HT<sub>4</sub> receptor agonistsJohn R Konen, Melody M Haag, Daria Guseva, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 19, 2016
German registry of paediatric deep brain stimulation in patients with childhood-onset dystonia (GEPESTIM)A Koy, M Weinsheimer, K A M Pauls, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutationsHelen Y Zou, Qiuhua Li, Lars D Engstrom, et al.
The New England Journal of Medicine|June 4, 2013
Acquired resistance to crizotinib from a mutation in CD74-ROS1Mark M Awad, Ryohei Katayama, Michele McTigue, et al.
Journal of Medicinal Chemistry|December 28, 2020
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)Hengmiao Cheng, Suvi T M Orr, Simon Bailey, et al.
The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.
Pageof 9